F. Dromer, S. Bretagne, and O. Lortholary, Rapport annuel d'activite ' -centre National de re 'fe 'rence Mycoses Invasives et Antifongiques, Institut Pasteur, 2016.

A. J. Ullmann, J. M. Aguado, S. Arikan-akdagli, D. W. Denning, A. H. Groll et al., Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clin Microbiol Infect, vol.24, pp.1-38, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01953645

O. A. Cornely, M. Bassetti, C. T. Garbino, J. Kullberg, B. J. Lortholary et al., ESCMID Guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin Microbiol Infect, vol.18, pp.19-37, 2012.

, Reference method for broth dilution antifungal susceptibility testing of yeasts. Fourth informational sup-plement M27-S4, 2012.

M. C. Arendrup, M. Cuenca-estrella, C. Lass-flo-?rl, and W. W. Hope, Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp, Drug Resist Updat, vol.16, pp.81-95, 2013.

, European Committee on Antimicrobial Susceptibility Testing EUCAST. Anti-fungal_breakpoints_v_9.0_180212. EUCAST, 2018.

J. Turnidge, G. Kahlmeter, and G. Kronvall, Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values, Clin Microbiol Infect, vol.12, pp.418-443, 2006.

S. R. Lockhart, M. A. Ghannoum, and A. Bd, Establishment and use of epide-miological cutoff values for molds and yeasts by use of the Clinical and Lab-oratory Standards Institute M57 Standard, J Clin Microbiol, vol.55, pp.1262-1270, 2017.

A. Espinel-ingroff and J. Turnidge, The role of epidemiological cutoff values (ECVs/ ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds, Rev Iberoam Micol, vol.33, pp.63-75, 2016.

A. Espinel-ingroff, J. Turnidge, A. Alastruey-izquierdo, E. Dannaoui, G. Garcia-effron et al., Posaconazole MIC distributions for Aspergillus fumi-gatus species complex by four methods: impact of cyp51A mutations on estimation of epidemiological cutoff values, Antimicrob Agents Chemother, vol.62, pp.1916-1923, 2018.

A. Espinel-ingroff, J. Turnidge, A. Alastruey-izquierdo, F. Botterel, E. Canton et al., Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods, Antimicrob Agents Chemother, vol.63, pp.1651-1669, 2018.

A. Espinel-ingroff, M. A. Pfaller, B. Bustamante, E. Canton, A. Fothergill et al., Multilaboratory study of epidemiological cutoff values for detection of species to fluconazole, posaconazole, and vor-iconazole, Antimicrob Agents Chemother, vol.58, 2014.

A. Espinel-ingroff, M. Arendrup, E. Canto-'n, S. Cordoba, E. Dannaoui et al., Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in Candida spp. and Aspergillus spp. to Amphotericin B and echinocandins for the Etest agar diffusion method, Anti-microb Agents Chemother, vol.61, pp.1792-1808, 2016.

J. Meletiadis, I. Curfs-breuker, J. F. Meis, and J. W. Mouton, In vitro antifungal suscep-tibility testing of Candida isolates with the EUCAST methodology, a new method for ECOFF determination, Antimicrob Agents Chemother, vol.61, pp.2372-2388, 2017.

M. A. Pfaller and D. J. Diekema, Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, J Clin Microbiol, vol.50, pp.2846-56, 2010.

M. A. Pfaller, A. Espinel-ingroff, B. Bustamante, E. Canton, D. J. Diekema et al., Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method, Antimicrob Agents Chemother, vol.58, pp.916-938, 2014.

, Epidemiological cutoff values for antifungal susceptibility testing M59, 2016.

A. Espinel-ingroff, A. Fothergill, J. Fuller, J. E. Pelaez, T. Turnidge et al., Wildtype MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document), Antimicrob Agents Chemother, vol.55, pp.2855-2864, 2011.

M. A. Pfaller, A. Espinel-ingroff, E. Canton, M. Castanheira, M. Cuenca-estrella et al., Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution, J Clin Microbiol, vol.50, pp.2040-2046, 2012.

. Sa, Etest antifungal susceptibility testing for in vitro diagnostic use package insert. Marcy l'E ' toile: bioMe 'rieux, 2013.

. Sa, Summary of etest. Performance interpretative criteria and quality control ranges. Marcy l'E ' toile: bioMe 'rieux, 2018.

S. J. Howard, C. Lass-flo-?rl, M. Cuenca-estrella, A. Gomez-lopez, and M. C. Arendrup, Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method, Antimicrob Agents Chemother, vol.57, pp.5426-5457, 2013.

, European Committee on Antimicrobial Susceptibility Testing EUCAST. EUCAST Antimicrobial wild type distributions of microorganisms, 2018.

A. J. Morris, K. Rogers, W. P. Mckinney, S. A. Roberts, and J. T. Freeman, Antifungal sus-ceptibility testing results of New Zealand yeast isolates, 2001e2015: impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species, J Glob Antimicrob Resist, vol.14, pp.72-79, 2018.

M. A. Pfaller, D. J. Diekema, R. N. Jones, and M. Castanheira, Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and inter-pretive criteria, J Clin Microbiol, vol.52, pp.3223-3232, 2014.

B. D. Alexander, T. C. Byrne, K. L. Smith, K. E. Hanson, K. J. Anstrom et al., Comparative evaluation of etest and Sensititre YeastOne panels against the clinical and laboratory standards Institute M27-A2 reference broth micro-dilution method for testing Candida susceptibility to seven antifungal agents, J Clin Microbiol, vol.45, pp.698-706, 2007.

D. Y. Metin, S. Hilmioglu-polat, P. Samlioglu, B. Doganay-oflazoglu, R. Inci et al., Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates, Mycopathologia, vol.172, pp.187-99, 2011.

A. Alastruey-izquierdo, L. Alcazar-fuoli, C. , and M. , Antifungal sus-ceptibility profile of cryptic species of Aspergillus, Mycopathologia, vol.178, pp.427-460, 2014.

M. Aigner, T. Erbeznik, and M. Gschwentner, Lass-Flo ?rl C. Etest and Sensititre Yea-stOne susceptibility testing of echinocandins against Candida species from a single center in Austria, Antimicrob Agents Chemother, vol.61, pp.512-519, 2017.

E. Dannaoui, A. Paugam, M. Develoux, C. Chochillon, J. Matheron et al., Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories, Clin Microbiol Infect, vol.16, pp.863-872, 2010.